Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitis

Retina

Volumn 31, Issue 8, 2011, Pages 1518-1524

  Callegan, Michelle C ^a,b   Guess, Scott ^a   Wheatley, Nanette R ^a   Woods, Dustin C ^a   Griffin, Gabe ^a   Wiskur, Brandt J ^c   Leonard, Robert ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Bacillus; eye; infection; vancomycin; vitrectomy

Indexed keywords

VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACILLUS CEREUS; BACILLUS CEREUS ENDOPHTHALMITIS; BACILLUS CEREUS INFECTION; CELL COUNT; CONTROLLED STUDY; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; HISTOLOGY; MALE; MONOTHERAPY; NONHUMAN; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VITRECTOMY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACILLUS CEREUS; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; LEUKOCYTE COUNT; MALE; NEUTROPHILS; RABBITS; RETINA; SPECIFIC PATHOGEN-FREE ORGANISMS; TREATMENT OUTCOME; VANCOMYCIN; VITRECTOMY; VITREOUS BODY;

EID: 80052516099     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318206d176     Document Type: Article

References (39)

1. Callegan MC, Gilmore MS, Gregory M, et al. Bacterial endophthalmitis: Therapeutic challenges and host-pathogen interactions. Prog Retin Eye Res 2007;26:189-203. (Pubitemid 46217162)
2. Gregory M, Callegan MC, Gilmore MS. Role of bacterial and host factors in infectious endophthalmitis. Chem Immunol Allergy 2007;92:266-275. (Pubitemid 47096915)
3. Meredith TA. Posttraumatic endophthalmitis. Arch Ophthalmol 1999;117:520-521. (Pubitemid 29169649)
4. Thompson ST, Parver LM, Enger CL, Meiler WF, Ligget PE. Infectious endophthalmitis after penetrating injuries with retained intraocular foreign bodies. Ophthalmology 1993; 100:1468-1474. (Pubitemid 23292856)
5. Davey RJ, Tauber WB. Posttraumatic endophthalmitis: The emerging role of Bacillus cereus infection. Rev Infect Dis 1987;9:110-123.
6. David DB, Kirkby GR, Noble BA. Bacillus cereus endophthalmitis. Br J Ophthalmol 1994;78:577-580. (Pubitemid 24213021)
7. O'Day DM, Smith RS, Gregg CR, et al. The problem of Bacillus species infection with special emphasis on the virulence of Bacillus cereus. Ophthalmology 1981; 88:833-838. (Pubitemid 11039472)
8. Callegan MC, Cochran DC, Kane ST, et al. Virulence factor profiles and antimicrobial susceptibilities of ocular Bacillus isolates. Curr Eye Res 2006;31:693-702. (Pubitemid 44373540)
9. Chhabra S, Kunimoto DY, Kazi L, et al. Endophthalmitis after open globe injury: Microbiologic spectrum and susceptibilities of isolates. Am J Ophthalmol 2007;142:852-854. (Pubitemid 44584128)
10. Miller JJ, Scott IU, Flynn Jr HW, et al. Endophthalmitis caused by Bacillus species. Am J Ophthalmol 2008;145:883-888.
11. Fujii GY, De Juan E Jr, Humayun MS, et al. Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology 2002;109:1814-1820.
12. Fine HF, Iranmanesh R, Iturralde D, Spaide RF. Outcomes of 77 consecutive cases of 23-gauge transconjunctival vitrectomy surgery for posterior segment disease. Ophthalmology 2007; 114:1197-1200.
13. Inoue Y, Kadonosono K, Yamakawa T, et al. Surgicallyinduced inflammation with 20-, 23-, and 25-gauge vitrectomy systems: An experimental study. Retina 2009;29:477-480.
14. Wiskur BJ, Robinson ML, Farrand AJ,Novosad BD, CalleganMC. Toward improving therapeutic regimens for Bacillus endophthalmitis. Invest Ophthalmol Vis Sci 2008;49:1480-1487.
15. Wiskur BJ, Woods DC, Wheatley NR, Callegan MC. Updates on improvements for therapy of severe bacterial endophthalmitis. Proc 8th Int Soc Ophth Pharmacol Ther. 2010;25-38.
16. Aguilar HE, Meredith TA, Drews C, Grossniklaus H, Sawant AD, Gardner S. Comparative treatment of experimental Staphylococcus aureus endophthalmitis. Am J Ophthalmol 1996;121:310-317. (Pubitemid 26085096)
17. Liu F, Kwok AK, Cheung BM. The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental Bacillus cereus endophthalmitis. Curr Eye Res 2008;33:761-768.
18. Liu SM,Way T, Rodrigues M, Steidl SM. Effects of intravitreal corticosteroids in the treatment of Bacillus cereus endophthalmitis. Arch Ophthalmol 2000;118:803-806. (Pubitemid 30395178)
19. Cheng CK, Yang CH, Hsueh PR, Liu CM, Lu HY. Vitrectomy with fluconazole infusion: Retinal toxicity, pharmacokinetics, and efficacy in the treatment of experimental candidal endophthalmitis. J Ocul Pharmacol Ther 2004;20:430-438.
20. Yang X, Dong XG, Liu AM, Sun SY, Xie LX, Wang SG. A pharmacodynamics study of an intravitreal amphotericin B drug delivery system for the treatment of experimental Aspergillus fumigatus endophthalmitis. Zhonghua Yan Ke Za Zhi 2007;43:546-553.
21. Kocxak N, Kaynak S, Kirdar S, Irmak O, Bahar IH. Comparison of different antifungal treatment regimens for experimental Candida endophthalmitis in rabbit models. Mikrobiyol Bul 2009;43:619-626.
22. Pollack JS, Beecher DJ, Pulido JS, Lee Wong AC. Failure of intravitreal dexamethasone to diminish inflammation or retinal toxicity in an experimental model of Bacillus cereus endophthalmitis. Curr Eye Res 2004;29:253-259. (Pubitemid 40095008)
23. Callegan MC, Kane ST, Cochran DC, Novosad B, Gilmore MS, Gominet M, Lereclus D. Bacillus endophthalmitis: Roles of bacterial toxins and motility during infection. Invest Ophthalmol Vis Sci 2005;46:3233-3238. (Pubitemid 44264310)
24. Callegan MC, Kane ST, Cochran DC, Gilmore MS, Gominet M, Lereclus D. Relationship of plcR-regulated factors to Bacillus endophthalmitis virulence. Infect Immun 2003;71:3116-3124. (Pubitemid 36637533)
25. Callegan MC, Jett BD, Hancock LE, Gilmore MS. Role of hemolysin BL in the pathogenesis of extraintestinal Bacillus cereus infection assessed in an endophthalmitis model. Infect Immun 1999;67:3357-3366. (Pubitemid 29291503)
26. CalleganMC, CochraneDC, Kane ST, GilmoreMS, GominetM, Lereclus D. Contribution of membrane-damaging toxins to Bacillus endophthalmitis pathogenesis. Infect Immun 2002;70: 5381-5389.
27. Ramadan RT, Ramirez R, Novosad BD, Callegan MC. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Curr Eye Res 2006;31:955-965.
28. Declerck N, Bouillaut L, Chaix D, et al. Structure of PlcR: Insights into virulence regulation and evolution of quorum sensing in gram-positive bacteria. Proc Natl Acad Sci U S A 2007;104:18490-18495. (Pubitemid 350210724)
29. Gohar M, Faegri K, Perchat S, et al. The PlcR virulence regulon of Bacillus cereus. PLoS One 2008;3:e2793.
30. Hsueh YH, Somers EB, Lereclus D, Wong AC. Biofilm formation by Bacillus cereus is influenced by PlcR, a pleiotropic regulator. Appl Environ Microbiol 2006;72:5089-5092. (Pubitemid 44078845)
31. Ramarao N, Lereclus D. Adhesion and cytotoxicity of Bacillus cereus and Bacillus thuringiensis to epithelial cells are FlhA and PlcR dependent, respectively. Microbes Infect 2006;8: 1483-1491. (Pubitemid 43922421)
32. Garner WH, Scheib S, Berkowitz BA, et al. The effect of partial vitrectomy on blood-ocular barrier function in the rabbit. Curr Eye Res 2001;23:372-381. (Pubitemid 34264326)
33. Stefánsson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 2009;247:147-163.
34. Sparrow JR, Chang S, Vinals AF. Evaluation of the bloodaqueous barrier after vitreous replacement with perfluoropropane gas and liquid silicone. Retina 1992;12:370-375. (Pubitemid 23033912)
35. Wallentén KG, Andréasson S, Ghosh F. Retinal function after vitrectomy. Retina 2008;28:558-563. (Pubitemid 351589564)
36. Lee SS, Ghosn C, Yu Z, et al. Vitreous VEGF clearance is increased following vitrectomy. Invest Ophthalmol Vis Sci. 2010;51:2135-2138.
37. Shimoda Y, Hamano R, Ishihara K, et al. Effects of intraocular irrigation with melphalan on rabbit retinas during vitrectomy. Graefes Arch Clin Exp Ophthalmol 2008;246:501-508. (Pubitemid 351447962)
38. Yamashita T, Sakamoto T, Yamakiri K, et al. Polylactic acid for visualizing the vitreous body during vitrectomy. Invest Ophthalmol Vis Sci 2007;48:3277-3282. (Pubitemid 351261174)
39. Gordon HA, Pesti L. The gnotobiotic animal as a tool in the study of host microbial relationships. Bacteriol Rev 1971;35: 390-429.